The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Sex differences in adverse event reporting in SWOG chemotherapy, biologic/immunotherapy, and targeted agent cancer clinical trials.
 
Joseph M. Unger
No Relationships to Disclose
 
Riha Vaidya
No Relationships to Disclose
 
Kathy S. Albain
Consulting or Advisory Role - Agendia; Genentech/Roche; Genentech/Roche; Genomic Health; Myriad Genetics; Novartis; Pfizer
Research Funding - Seagen; Seagen (Inst)
Other Relationship - Puma Biotechnology
 
Michael Leo LeBlanc
No Relationships to Disclose
 
Lori M. Minasian
No Relationships to Disclose
 
Carolyn Gotay
No Relationships to Disclose
 
Norah Lynn Henry
Research Funding - Abbvie (Inst); H3 Biomedicine (Inst); Innocrin Pharma (Inst); Pfizer (Inst)
 
Michael Jordan Fisch
Employment - AIM Specialty Health
Stock and Other Ownership Interests - Anthem
Consulting or Advisory Role - WellPoint
Patents, Royalties, Other Intellectual Property - Healthcore, Inc. A subsidiary of Anthem, Inc.
 
Scott David Ramsey
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; Cascadian Therapeutics; Epigenomics; Genentech; Kite, a Gilead company; Merck; Seagen
Research Funding - Bayer (Inst); Bristol-Myers Squibb (Inst); Microsoft (Inst)
Travel, Accommodations, Expenses - Bayer Schering Pharma; Bristol-Myers Squibb; Flatiron Health
 
Charles David Blanke
No Relationships to Disclose
 
Gary H. Lyman
Stock and Other Ownership Interests - Generex Biotechnology
Consulting or Advisory Role - Agendia; Amgen; Celldex (I); G1 Therapeutics; Genomic Health; Halozyme; Helsinn Therapeutics; Janssen (I); Mylan; Partners Healthcare; Pfizer; Samsung Bioepis; Spectrum Pharmaceuticals
Research Funding - Hexal
 
Dawn L. Hershman
Consulting or Advisory Role - AIM Specialty Health